InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Greenberg Eric Howard. Director active across 1 company, notably Titan Pharmaceuticals INC. Cumulatively, 2 reports have been recorded. History available since 26 July 2023. The latest transaction was filed on 25 October 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations